Overview

Positron Emission Tomography (PET) Study With (11C)Flumazenil to Determine Central GABAA Receptor Occupancy of AZD7325

Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The study is carried out in order to determine the relationship between the dose of AZD7325 and the blood concentration of AZD7325, and to investigate to which extent AZD7325 binds to the GABAA receptors.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Flumazenil